LifeStance Health Group, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by LifeStance Health Group, Inc. on August 6, 2026. The filing primarily announces the Company's results of operations for the second quarter ended June 30, 2026, and discloses a new share repurchase program approved by the Board of Directors on August 5, 2026.
Key Financial Metrics
The filing text references a press release (Exhibit 99.1) and a slide presentation (Exhibit 99.2) containing specific financial data. However, the body of this Form 8-K does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached exhibits for these specific metrics.
Material Changes and Corporate Actions
- Share Repurchase Program: The Board approved a new program authorizing the repurchase of up to $100 million of outstanding common stock.
- Program Replacement: This new authorization replaces the prior $100 million repurchase program approved on February 24, 2026.
- Execution Flexibility: The Company is not obligated to repurchase any specific amount. Repurchases may be conducted via open market, privately negotiated transactions, accelerated share repurchase programs, or block purchases, depending on market conditions and corporate requirements.
Guidance, Outlook, and Risks
The filing includes a Regulation FD disclosure regarding a slide presentation with supplemental information. The text does not contain specific forward-looking guidance, management commentary on future performance, or a detailed discussion of risks and contingencies within the main body of the report. The Company notes that the information in the exhibits is not deemed "filed" for purposes of Section 18 of the Exchange Act unless expressly incorporated by reference.
Key Facts for Investor Verification
- Verify specific Q2 2026 financial results (revenue, net income, EPS) in the attached Press Release (Exhibit 99.1).
- Confirm the status of the previous $100 million repurchase program and the remaining authorization under the new program.
- Review the supplemental slide presentation (Exhibit 99.2) for any updated operational metrics or strategic outlook not detailed in the press release.
- Monitor future filings for actual execution of the new share repurchase program.